Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Skin Neoplasms × Natalizumab × Clear all

Sponsor

Conditions

Recurrence 1 Neoplasm Metastasis 1 Multiple Sclerosis, Chronic Progressive 1 Multiple Sclerosis 1 Multiple Myeloma 1

Interventions

aldesleukin 15 Cyclophosphamide 15 fludarabine phosphate 12 fludarabine 11 Interleukin-2 10 Nivolumab 6 Ipilimumab 6 Temozolomide 5 pembrolizumab 3 Fluorouracil 3 trametinib 2 sonidegib 2 dabrafenib 2 binimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Sodium Chloride 2 Sirolimus 2 Radiotherapy 2 Radiation 2 Peptides 2 HhAntag691 2 Gefitinib 2 Dacarbazine 2 Cyclosporine 2 Capecitabine 2 veliparib 1 varlilumab 1 tilsotolimod 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡